Indication

Streptococcus pericarditis

Streptococcus pericarditis is an acute, severe bacterial infection of the pericardial sac caused by species of the genus *Streptococcus*, commonly *Streptococcus pneumoniae*, viridans group streptococci, or beta-hemolytic streptococci. Read more about Streptococcus pericarditis

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Streptococcus pericarditis therapies.

Showing 1–9 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Streptococcus pericarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Streptococcus pericarditis.

Streptococcus pericarditis is an acute, severe bacterial infection of the pericardial sac caused by species of the genus *Streptococcus*, commonly *Streptococcus pneumoniae*, viridans group streptococci, or beta-hemolytic streptococci.

It primarily affects the cardiovascular system across both pediatric and adult populations, frequently arising via direct extension from adjacent intrathoracic infections, hematogenous seeding, or contiguous spread from infective endocarditis.

Pathophysiologically, the condition manifests as suppurative or purulent inflammation characterized by dense fibrinous exudates, neutrophil infiltration, and rapid accumulation of purulent pericardial effusion.

Without prompt intervention, it commonly leads to life-threatening hemodynamic compromise, including cardiac tamponade, systemic sepsis, and subsequent constrictive pericarditis.

Personalize your experience

Follow Streptococcus pericarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it